| |
Browse
Categories
Addictions
Beauty
Child Health
Dentistry
Disabilities
Environmental Health
Fitness
Home Health
Medicine
Mens Health
News and Media
Nursing
Nutrition
Reproductive Health
Senior Health
Shopping
Specific Substances
Surgery
Teen Health
Weight Loss
|
Medline Plus: Multiple Endocrine Neoplasia (MEN) I Provides the definition, symptoms, risk factors, complications, and treatment. Includes illustrations.
http://www.nlm.nih.gov/medlineplus/ency/article/000398.htm
Multiple Endocrine Neoplasia Contains questions and answers about this disease in detail. By Genetics Home Reference.
http://ghr.nlm.nih.gov/condition=multipleendocrineneoplasia
Multiple Endocrine Neoplasia Syndromes Covers the definition, causes, treatment, prognosis, prevention, and resources. Contains illustration.
http://www.vhi.ie/topic/topic100587166
Multiple Endocrine Neoplasia Type 1 eMedicine's description of symptoms, diagnosis, and treatment issues. Contains photos.
http://www.emedicine.com/derm/topic532.htm
Multiple Endocrine Neoplasia Type 1 National Institute of Health provides questions and answers to this inherited disorder that affects the endocrine glands.
http://www.niddk.nih.gov/health/endo/pubs/fmen1/fmen1.htm
Multiple Endocrine Neoplasia Type 2 (MEN 2) EndocrineWeb describes this very uncommon inherited disease, its effects on the endocrine glands, the age it usually presents itself, and treatment.
http://www.endocrineweb.com/MEN/MEN2.html
Multiple Endocrine Neoplasia Type1 (MEN1) Email list group to make friends, share information, and provide support for persons affected by this disorder.
http://health.groups.yahoo.com/group/MEN1/
Multiple Endocrine Neoplasia, Type 2 Contains an introduction, clinical aspects, differentials, workup, treatment, and medications. From eMedicine.
http://www.emedicine.com/med/topic1520.htm
The Association for Multiple Endocrine Neoplasia Disorders AMEND is a resource for patients throughout the world who have the rare hereditary conditions of MEN Type 1 or Type 2.
http://www.amend.org.uk/
|
|
|
|
|
